Camu-Camu is an exotic fruit original from the Amazon. Recent studies, however, revealed that this strange fruit might help fight obesity and metabolic disorders by having a positive impact on the beneficial gut bacteria.
Obesity is an increasingly more significant problem around the world, and experts assess that more than 1 billion people worldwide will be overweight by 2030, so, the obesity risk increases even more. Accordingly, experts say, comprehending the mechanisms behind obesity is crucial.
Some recent studies concluded that gut bacteria play an essential role in metabolism and any disorder in the intestinal microbiota might cause overweight and obesity which could lead to more severe conditions.
Consuming fruits, which are rich in polyphenols, improves the gut bacteria, besides benefiting the overall health. But, the exotic fruit Camu-Camu has been recently found to be extremely beneficial against obesity by reducing weight and regulating the insulin resistance.
Scientists at the Universite Laval’s Faculty of Medicine in Canada recently explored the possible beneficial effects Myrciaria dubia, also known as Camu-Camu. According to their research, this exotic fruit, common in Peru and Brazil, is reddish-purple fruit very similar to cherry.
Even though it’s not very tasty fruit, Camu-Camu, very popular in Japan, is usually mixed with lime and cherry.
Camu-Camu fights obesity
This exotic fruit is very rich in Vitamin C, totaling 3,000 milligrams per 100 grams, and phytochemicals, features that make it a great ally against metabolic disorders and obesity.
When testing the potential benefits of Camu-Camu on lab mice, the researchers discovered that the insulin resistance in mice (fed with a high-fat, high-sugar diet) improved significantly, as well as the blood sugar levels.
“All these changes were accompanied by a reshaping of the intestinal microbiota (gut bacteria), including a blooming of Akkermansia muciniphila and a significant reduction in Lactobacillus bacteria,” explained Andre Marette, a professor at the Universite Laval’s Faculty of Medicine in Canada.